Malinda was born with cerebral palsy, epilepsy, total blindness, and cognitive delays. She was recently diagnosed with severe osteoporosis which has caused portions of her bones to literally disintegrate and triggered chronic and excruciating pain. After Malinda nearly died from serious adverse reactions to pharmaceutical painkillers, including OxyContin, her mother and pain-specialist tried a natural approach: medical marijuana. Within days, Malinda’s kidneys began functioning again and her pain became manageable. Malinda’s mother, once a staunch anti-drug advocate, now pushes Malinda, in her wheelchair, to the Beach Cities Collective to obtain her life-saving medicine.
But, the Collective’s future is uncertain due to Dana Point’s crusade to close down every collective in that city. City Attorney, Patrick Munoz, calls the collectives “criminal enterprises” because he says they have not proven otherwise. Malinda’s attorney, Jeff Schwartz, says that’s absurd. “Under the law,” says Schwartz, “neither people nor collectives have to prove anything. If the government believes that illegal activities are going on, it’s the government’s burden to prove it.”
A lot οf things wеrе ѕаіԁ аbουt medical marijuana аnԁ іtѕ employment іn thе modern society аnԁ medicine. Sοmе believe thаt marijuana іѕ medically valuable, others don’t. Anyway, medical marijuana wаѕ shown tο cure headaches, nausea, muscle spasms аnԁ stomach cramps, аnԁ even such bаԁ diseases, Ɩіkе cancer, Parkinson’s disease, аnԁ Alzheimer’s disease. Today, іn thе US, thе number οf people thаt ѕtаrt tο υѕе medical Marijuana Treatment gradually increases. Up tο thе date, thеrе аrе 14 states thаt hаνе legalized cannabis fοr medicinal employment. Verify wіth уουr state regulations tο find out іf уου аrе allowed tο еmрƖοу medical marijuana.
Sativex®, available as a prescription only medicine, was developed by GW in specific response to calls from people with MS for a prescription cannabis-based medicine. Today’s launch means that MS patients suffering the spasms and cramping associated with spasticity have access to a new treatment option which has been shown to improve their symptoms where current treatments have failed.
Sativex® is manufactured by GW under Home Office licence at an undisclosed location in the UK. The medicine is being marketed in the UK by GW’s UK licensee, Bayer Schering Pharma.
As Jennifer Maxey describes it, medical marijuana has been a godsend for her 16-year-old son, Austin.
Austin has Ehlers-Danlos syndrome, a genetic disorder characterized by chronic pain.
In the hope of getting Austin off the debilitating pain killers he was taking, Maxey decided to try medicinal cannabis, legalized by Michigan voters in 2008. She went through the necessary steps, getting written certification from Austin’s doctor, then a medical marijuana registry identification card from state Department of Community Health.
Austin started using marijuana – less than a gram a week (there are about 28 grams in an ounce) – in March. Maxey, who lives in Lansing, buys pre-made muffins, candy and oil from the designated caregiver.
Maxey described the result as “phenomenal.”
“He’s a completely different child,” the mother said. “He used to be a recluse; now he asks to go places with me.”
Marijuana can be a promising treatment for some specific, pain-related medical conditions, according to California researchers who presented an update of their findings Wednesday to the California Legislature and also released them to the public.
Hi, I’m Dr Robert Melamede PhD. I’m a professor at the University of Colorado at Colorado Springs. I was the former chairman of the biology department there. And currently in addition to my role as professor I am also the CEO and president of Cannabis Science a publicly traded company on the NASDAC bulletin board (CBIS). I was studying free radicals in that I was studying radiation chemistry and DNA repair. So that gave me a foundation to understand free radicals as very important modulators, essentially of aging and age related illnesses. Which is really what cannabis does. So, by combining my understanding of life from the thermodynamic point of view, pharma-equilibrium thermodynamic point of view in conjunction with my expertise in radiation chemistry and free radicals and being a lifelong cannabis user, I have been in a very unique position to assemble those three entities into a cohesive perspective as to what life is and the fundamental role that the endocannabinoid system plays in life and how it modulates a imbalance we all suffer.
With the recent interest in medical cannabis and cannabinoid therapeutics, old businesses are adapting.
At last weeks Medical Cannabis Summit in San Francisco, all heads came together to discuss many topics surrounding clinical cannabis. One of the most important topics discussed was how to proceed with clinical cannabis and cannabinoid research, and one of the ways you can help is to encourage our leaders to grant more licensing for clinical cannabis cultivation for federally-approved research.
Below is a sample from our friends at Students For Sensible Drug Policy (SSDP) to help guide you should this be a new experience for you.
This is what separates us from people who just have a headache. They take a Tylenol. 2 hours from now, they’re fine, they move on. Someone with a chronic illness doesn’t walk away from that illness. We live with that the rest of our lives, we deal with it the rest of our lives. I’ve often said it before, people I’ve interviewed before, I said, when the cameras go off, they go home, they, are still chronically ill. They’re still dealing with that health issue. That’s an important thing to understand, when people say, well, there are prescription drugs that can take care of that illness, the unfortunate thing is with prescription drugs is, all prescription drugs, are only meant to be temporary, only meant for a period of time.
My name is Irvin Rosenfeld and I’m the longest surviving federal medical cannabis patient in the United States. In 1972 to 1982 I took on the federal government and in ’82 I became the second patient in the country to receive cannabis from the federal government.